Welcome to Medications.com

Warner Chilcott Announces 2008 Financial Guidance - netPR.pl (komunikaty prasowe)

(1) Our 2008 guidance assumes generic competition for DOVONEX solution in 1Q08 and SARAFEM in 2Q08. Our 2008 guidance does not account for the impact of any ...

http://media.netpr.pl/notatka_924... | Posted: Mon Jan 28 07:40:38 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea